NIH Clinical Trial Integrity Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill expands a appropriation, grant, reporting req provision: 2. Diversity goals for clinical trials funded by the National Institutes of Health Beginning on the date of enactment of this Act, the Secretary of Health, adds or tightens a reporting req, compliance mandate, delegation of rulemaking provision: 3. Eliminating cost barriers, and expands a appropriation, grant, reporting req provision: 4. Public awareness and education campaign. It relies on reporting requirements, appropriations, grants, and compliance mandates. The main policy areas are Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Expands a appropriation, grant, reporting req provision: 2. Diversity goals for clinical trials funded by the National Institutes of Health Beginning on the date of enactment of this Act, the Secretary of Health...
- Adds or tightens a reporting req, compliance mandate, delegation of rulemaking provision: 3. Eliminating cost barriers.
- Expands a appropriation, grant, reporting req provision: 4. Public awareness and education campaign.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill expands a appropriation, grant, reporting req provision: 2. Diversity goals for clinical trials funded by the National Institutes of Health Beginning on the date of enactment of this Act, the Secretary of Health, adds or tightens a reporting req, compliance mandate, delegation of rulemaking provision: 3. Eliminating cost barriers, and expands a appropriation, grant, reporting req provision: 4. Public awareness and education campaign.
Key Policy Areas
Healthcare
Primary Purpose
The bill expands a appropriation, grant, reporting req provision: 2. Diversity goals for clinical trials funded by the National Institutes of Health Beginning on the date of enactment of this Act, the Secretary of Health, adds or tightens a reporting req, compliance mandate, delegation of rulemaking provision: 3. Eliminating cost barriers, and expands a appropriation, grant, reporting req provision: 4. Public awareness and education campaign.
Policy Domains
Sponsors
Andy Kim
D-NJ | Primary Sponsor
Legislative Progress
In CommitteeMr. Kim (for himself and Ms. Collins) introduced the following …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_director"
- → Director of the National Institutes of Health
- "the_secretary"
- → Secretary of Health and Human Services
- "the_director"
- → Director of the National Institutes of Health
- "the_secretary"
- → Secretary of Health and Human Services
- "the_secretary"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology